The Providence Thoracic Oncology Program emphasizes a multidisciplinary approach to cancer management. Our clinical trials program offers a broad array of innovative clinical research, including studies of new surgical techniques, radiation, chemotherapy, targeted therapy and immunotherapy agents, and tissue banking.
A breakthrough drug for treating the most common type of lung cancer was just approved by the Food and Drug Administration ahead of schedule following two successful clinical trials, including one that involved patients at Providence Cancer Center in Portland.
To influence through education and inspire through example to promote a tobacco free world.
Rebels for a Cause is made up of roughly 65 high school...
November is Lung Cancer Awareness month. More people in the United States die from lung cancer than any other type of cancer. But that could change because now, like mammograms and colonoscopies, regular lung cancer screenings for people with risk factors may be an option.
Federal government health experts recently released a draft report which said, for the first time, there is evidence screening of smokers may save them from dying of lung cancer.
People who use electronic cigarettes may believe they’re making a healthier smoking choice. But since e-cigarettes are unregulated at this time, it’s not fully known what’s in the vapor these non-tobacco cigarettes emit.
Providence School Outreach hosted more than 125 high school students for a live “Chest Watch” surgery as Dr. John Handy performed an initial lung thoracoscopy and then lobectomy on a life-long smoker.
Even if boomers are able to kick the smoking habit – or even if they never smoked at all – they still may be at risk of lung cancer.
In honor of The Great American Smokeout on Nov. 15, Dr. Jain explains why quitting is so hard and offers ways to help kick the habit.
Providence begins work on national lung cancer collaborative